Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047801
Status:
COMPLETED
Last Update Posted:
2011-07-25
First Post:
2002-10-18
Brief Title:
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
Sponsor:
Telik
Organization:
Telik
Organization Data
Organization:
Telik
Class:
INDUSTRY
Study ID:
TLK2862012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Telik
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gail Brown MD Chief Medical Officer
Old Organization:
Telik Inc